93 related articles for article (PubMed ID: 1032572)
1. The effect of prindolol on plasma noradrenaline, plasma renin and sodium-potassium metabolism in patients with essential hypertension.
Brecht HM; Werner E; Schoeppe W
Adv Clin Pharmacol; 1976; 11():66-9. PubMed ID: 1032572
[TBL] [Abstract][Full Text] [Related]
2. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
[TBL] [Abstract][Full Text] [Related]
3. Circulatory volume in essential hypertension. Relationships with age, blood pressure, exchangeable sodium, renin, aldosterone and catecholamines.
Beretta-Piccoli C; Weidmann P
Miner Electrolyte Metab; 1984; 10(5):292-300. PubMed ID: 6387428
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
Weber MA; Stokes GS; Gain JM
J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
[TBL] [Abstract][Full Text] [Related]
5. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
Man in't Veld AJ; Schalekamp MA
Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
[TBL] [Abstract][Full Text] [Related]
6. [Blood pressure and renin activity in essential hypertension under pindolol].
Nussberger J; Vetter W; Furrer J; Beckerhoff R; Würsten D; Schmied U; Siegenthaler W
Schweiz Med Wochenschr; 1976 Jun; 106(24):831-4. PubMed ID: 996500
[TBL] [Abstract][Full Text] [Related]
7. Effects of prolonged and brief infusions of noradrenaline on arterial pressure and on the plasma concentrations of active renin, angiotensin II, aldosterone and potassium.
Casals-Stenzel J; Tree M; Brown JJ; Fraser R; Lever AF; Millar JA; Morton JJ; Robertson JI; Reid JL; Hamilton C
J Hypertens; 1983 Jun; 1(1):27-35. PubMed ID: 6397510
[TBL] [Abstract][Full Text] [Related]
8. Effects of nisoldipine on sympathetic activity, the renin-angiotensin-aldosterone system, and water-sodium-calcium metabolism in patients with essential hypertension.
Iimura O; Kikuchi K; Shimamoto K; Nozawa A; Hasegawa R; Homma C; Komura H; Kobayakawa H
Arzneimittelforschung; 1989 Jun; 39(6):710-4. PubMed ID: 2775339
[TBL] [Abstract][Full Text] [Related]
9. [The effect of prindolol on the blood-pressure profile of hypertensives (with special consideration of response to exercise and plasma-renin activity) (author's transl)].
Dufey K; Krönig B; Fries G; Gunkel R; Walter U; Wolff HP
Dtsch Med Wochenschr; 1975 Aug; 100(35):1726-30. PubMed ID: 1157670
[TBL] [Abstract][Full Text] [Related]
10. Effect of pindolol and propranolol on plasma renin and aldosterone in patients with renal allograft.
Wehling M; Kuhlmann U; Záruba K; Largiadèr F; Keusch G; Studer A; Vetter W
Clin Nephrol; 1983 Nov; 20(5):231-4. PubMed ID: 6360452
[TBL] [Abstract][Full Text] [Related]
11. Beta-adrenoceptor stimulating and blocking agents in essential hypertension: single and combined therapy with terbutaline and metoprolol.
Schulte KL; Meyer-Sabellek W; Thiede HM; Röcker L; Gotzen R
Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):539-44. PubMed ID: 3323072
[TBL] [Abstract][Full Text] [Related]
12. Increase of total body potassium and decrease of exchangeable sodium after long-term treatment with a beta-receptor-blocking agent (prindolol) in essential hypertension.
Brecht HM; Werner E; Schoeppe W
Clin Sci Mol Med Suppl; 1976 Dec; 3():551s-554s. PubMed ID: 1071679
[TBL] [Abstract][Full Text] [Related]
13. [Effect of pindolol (Visken) on blood pressure and plasma renin activity in various forms of hypertension].
Werning C; Vetter H
Adv Clin Pharmacol; 1976; 11():54-60. PubMed ID: 1032571
[TBL] [Abstract][Full Text] [Related]
14. Effect of renin-angiotensin system activation by dietary sodium restriction and upright position on plasma leptin concentration in patients with essential hypertension.
Adamczak M; Kokot F; Chudek J; Wiecek A
Med Sci Monit; 2002 Jul; 8(7):CR473-7. PubMed ID: 12118193
[TBL] [Abstract][Full Text] [Related]
15. [Plasma renin and noradrenalin levels during hypotensive therapy using acebutolol (author's transl)].
Plouin PF; Comoy E; Bohuon C; Corvol P; Ménard J
Nouv Presse Med; 1979 May; 8(23):1905-9. PubMed ID: 461152
[TBL] [Abstract][Full Text] [Related]
16. Decrease in plasma noradrenaline levels following long-term treatment with prindolol in patients with essential hypertension.
Brecht HM; Banthien F; Schoeppe W
Klin Wochenschr; 1976 Nov; 54(22):1095-105. PubMed ID: 1003867
[TBL] [Abstract][Full Text] [Related]
17. Plasma catecholamines, renin and aldosterone during combined alpha- and beta- adrenoceptor blockade in patients with severe arterial hypertension.
Kornerup HJ; Pedersen EB; Pedersen A; Pedersen G; Christensen NJ
Postgrad Med J; 1980; 56 Suppl 2():49-52. PubMed ID: 7001422
[TBL] [Abstract][Full Text] [Related]
18. Guanfacine in essential hypertension: effect on blood pressure, plasma noradrenaline concentration and plasma renin activity.
Schoeppe W; Brecht HM
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):97S-101S. PubMed ID: 6994788
[TBL] [Abstract][Full Text] [Related]
19. [Sodium outflow rate through lymphocyte cell membranes, serum levels of sodium, potassium, aldosterone, total catecholamines, 6-keto- PGF2alpha and plasma renin activity in patients with primary arterial hypertension treated with captopril].
Mazurek W; Halawa B; Borejko-Słopecka G
Pol Tyg Lek; 1992 Jul 6-13; 47(27-28):588-93. PubMed ID: 1488334
[TBL] [Abstract][Full Text] [Related]
20. Effects of felodipine on blood pressure and humoral factors in sodium-replete humans at rest and during exercise.
Lijnen P; Hespel P; Fagard R; Staessen J; M'Buyamba-Kabangu JR; Moerman E; Amery A
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S122-5. PubMed ID: 2455111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
